A detailed history of Accordant Advisory Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Accordant Advisory Group Inc holds 115 shares of ABT stock, worth $13,542. This represents 0.01% of its overall portfolio holdings.

Number of Shares
115
Previous 115 -0.0%
Holding current value
$13,542
Previous $12 Million 9.72%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$109.52 - $120.96 $12,594 - $13,910
115 New
115 $13.1 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Accordant Advisory Group Inc Portfolio

Follow Accordant Advisory Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accordant Advisory Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Accordant Advisory Group Inc with notifications on news.